{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:52:45Z","timestamp":1792623165503,"version":"4.5.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"SI2","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study is to investigate the effect of anti-interleukin (IL)-1\/-6 biologics on systemic juvenile idiopathic arthritis (sJIA)-associated macrophage activation syndrome (MAS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic, clinical and laboratory data of patients followed up with a diagnosis of sJIA-associated MAS assessed from sixteen paediatric rheumatology centres across the country. The clinical and laboratory features of MAS developing while on biological drugs were compared with those without this treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and sixty-two patients were included in the study. Forty-five of the MAS events were detected under the effect of anti-IL-1\/-6 biologics, while the patients experiencing the remaining 155 events have not received biological treatment in the last three months. Platelet count [128 (72\u2013232) vs 199 (130\u2013371) 109\/l], ferritin level on admission [1107 (676\u20132050) vs 2863 (1193\u20139562) ng\/ml], C-reactive protein level [15.4 (2.9\u201356) vs 90 (32\u2013160) mg\/l], erythrocyte sedimentation rate [13 (3\u201336) vs 43.5 (13\u201377) mm\/h] and fever duration [5 (4\u20137.5) vs 10 (7\u201314.3) days] were found lower in the group under the impact of anti-IL-1\/-6 biologics. Among patients treated with biologics, 26.6% did not meet the published 2016 MAS classification criteria at presentation. The rates of hepatomegaly and splenomegaly were relatively lower in the canakinumab-treated group when compared with those receiving other biologicals or to patients, not on biologicals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-IL-1\/-6 therapies can mask the clinical and laboratory features of MAS, and proposed guidelines for MAS classification criteria may not be met.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae124","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T09:30:13Z","timestamp":1709285413000},"page":"SI167-SI172","source":"Crossref","is-referenced-by-count":10,"title":["Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-6077","authenticated-orcid":false,"given":"Kadir","family":"Ulu","sequence":"first","affiliation":[{"name":"Department of Pediatric Rheumatology, \u00dcmraniye Training and Research Hospital , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Aliyev","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Hacettepe University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"K\u0131l\u0131\u00e7 K\u00f6nte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University-Cerrahpasa , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-4575","authenticated-orcid":false,"given":"Ay\u015fe","family":"Tanatar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-0361","authenticated-orcid":false,"given":"\u015eeyma","family":"T\u00fcrkmen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u00dcmraniye Training and Research Hospital , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyda","family":"Do\u011fantan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University , Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"K\u0131z\u0131lda\u011f","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Dokuz Eyl\u00fcl University , \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belde","family":"Kasap Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Tepecik Training and Research Hospital , \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-2076","authenticated-orcid":false,"given":"Deniz","family":"Gezgin Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Gazi University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-6309","authenticated-orcid":false,"given":"G\u00fcl\u00e7in","family":"Otar Yener","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Gaziantep Medical Point Hospital , Gaziantep, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-0228","authenticated-orcid":false,"given":"K\u00fcbra","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul Medeniyet University , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Karadeniz Technical University , Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceyhun","family":"A\u00e7ar\u0131","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130n\u00f6n\u00fc University , Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fah","family":"K\u0131lba\u015f","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Pamukkale University , Denizli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema Nur","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University , Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Ha\u015flak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University-Cerrahpasa , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeng\u00fcl","family":"\u00c7a\u011flayan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u00dcmraniye Training and Research Hospital , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-8553","authenticated-orcid":false,"given":"Esra","family":"Ba\u011flan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Dr Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1469-9900","authenticated-orcid":false,"given":"Hatice Ad\u0131g\u00fczel","family":"Dundar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Van Training and Research Hospital , Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Ba\u015faran","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Hacettepe University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University-Cerrahpasa , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eerife G\u00fcl","family":"Karada\u011f","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Co\u015fkuner","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u00dcmraniye Training and Research Hospital , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafize Emine","family":"S\u00f6nmez","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Kocaeli University , Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"Y\u00fcksel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Pamukkale University , Denizli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaddes","family":"Kalyoncu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Karadeniz Technical University , Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan A","family":"Bakkalo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Gazi University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erbil","family":"\u00dcnsal","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Dokuz Eyl\u00fcl University , \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fenur","family":"Pa\u00e7 K\u0131saarslan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University , Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Hacettepe University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray","family":"Aktay Ayaz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"\u00d6zg\u00fcr","family":"Kasap\u00e7opur","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u0130stanbul University-Cerrahpasa , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Hacettepe University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, \u00dcmraniye Training and Research Hospital , \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"2024090907515229000_keae124-B1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/25785826.2021.1912893","article-title":"Macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"44","author":"Shimizu","year":"2021","journal-title":"Immunol Med"},{"key":"2024090907515229000_keae124-B2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/14397595.2019.1660026","article-title":"The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis","volume":"30","author":"\u00c7akan","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2024090907515229000_keae124-B3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"2024090907515229000_keae124-B4","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024090907515229000_keae124-B5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American college of rheumatology\/Paediatric rheumatology international trials organisation collaborative initiative","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024090907515229000_keae124-B6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.berh.2014.03.002","article-title":"Macrophage activation syndrome and cytokine-directed therapies","volume":"28","author":"Schulert","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2024090907515229000_keae124-B7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024090907515229000_keae124-B8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14740338.2021.1843631","article-title":"Safety and efficacy of anakinra as first-line or second-line therapy for systemic onset juvenile idiopathic arthritis\u2014data from the German BIKER registry","volume":"20","author":"Atemnkeng Ntam","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"2024090907515229000_keae124-B9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/annrheumdis-2018-213150","article-title":"Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials","volume":"77","author":"Ruperto","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024090907515229000_keae124-B10","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/art.41436","article-title":"Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: results From an Open-Label, Active-Treatment Extension Study","volume":"72","author":"Brunner","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2024090907515229000_keae124-B11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3899\/jrheum.140288","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab","volume":"42","author":"Yokota","year":"2015","journal-title":"J Rheumatol"},{"key":"2024090907515229000_keae124-B12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2024090907515229000_keae124-B13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.39407","article-title":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab","volume":"68","author":"Grom","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024090907515229000_keae124-B14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2024090907515229000_keae124-B15","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2024090907515229000_keae124-B16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2024090907515229000_keae124-B17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"key":"2024090907515229000_keae124-B18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2024090907515229000_keae124-B19","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"key":"2024090907515229000_keae124-B20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","article-title":"IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review","volume":"29","author":"Ogata","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2024090907515229000_keae124-B21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jbspin.2016.04.008","article-title":"Tocilizumab-induced hypofibrinogenemia: a report of 7 cases","volume":"84","author":"Martis","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2024090907515229000_keae124-B22","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1093\/rheumatology\/keaa121","article-title":"Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry","volume":"59","author":"Sag","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae124\/56973882\/keae124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/SI2\/SI167\/59038605\/keae124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/SI2\/SI167\/59038605\/keae124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:54:14Z","timestamp":1725854054000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/SI2\/SI167\/7619294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":22,"journal-issue":{"issue":"SI2","published-online":{"date-parts":[[2024,3,5]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae124","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,3,5]]}}}